We partner with the media to inform the public of the global human crisis.
Latest News
-
December 12, 2018
Court of Appeals for the Federal Circuit Declines to Immediately Issue Mandate After Preliminary Injunction Ruling... -
November 30, 2018
Indivior Prepays Debt... -
November 27, 2018
Indivior Conference Call, Previously-scheduled Capital Markets Day to be held in February 2019... -
November 23, 2018
Indivior Announces Health Canada Approval of SUBLOCADE™ (Buprenorphine Extended-Release) Injection for Patients with Moderate to Severe Opioid Use Disorder... -
November 21, 2018
Court of Appeals for the Federal Circuit Lifts Preliminary Injunction on Generic (buprenorphine and naloxone) Sublingual Film...
Upcoming Events
-
Tuesday, December 18th
Indivior Conference Call, Previously-scheduled Capital Markets Day to be held in February 2019 >
-
November 13th
Stifel 2018 Healthcare Conference >
-
November 6th, 2018
Indivior Announces Upcoming Investor Events >
-
Thursday, November 1st
Nine Months Year-to-Date & Q3 2018 Results Webcast. >
Global Media Contacts
Email: IndiviorMediaContacts@indivior.com
Phone: +1 804-594-0836
UK Media Contacts
Tulchan Communications LLP
85 Fleet Street
London
EC4Y 1AE
Indivior@Tulchangroup.com
Phone: +44 (020) 7353 4200
EMEA, Australasia and China Financial Disclosure Reporting
Disclosure Of Payments, Donations & Joint Working
Media Kit
The Online Press Kit is designed to help media research our company for background information or follow-up stories. Please visit the links below to learn more.
About Indivior PLC – An overview of Indivior, including our worldwide locations and key products
Board of Directors – Biographies of Indivior’s Board
The Indivior PLC Pipeline – Information about the Indivior R&D efforts and progress of medicines in the pipeline